Kathryn Kolibaba, MD of US Oncology Research gives an overview of the results from the BRIGHT study and its impact on treatment for indolent non-hodgkin lymphoma patients. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Results of BRIGHT study in front line indolent non-hodgkin lymphoma patients
